CAS NO: | 668467-91-2 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | LDN-57444 is a reversible, competitive and site-directed inhibitor ofubiquitin C-terminal hydrolase L1 (UCH-L1), with anIC50of 0.88 μM and aKiof 0.40 μM; LDN-57444 also suppressesUCH-L3activity, with anIC50of 25 μM. | ||||||||||||||||
IC50& Target | IC50: 0.88 μM (UCH-L1), 25 μM (UCH-L3)[1] | ||||||||||||||||
体外研究 (In Vitro) | LDN-57444 is a reversible, competitive inhibitor of UCH-L1, with an IC50of 0.88 μM, and also suppresses UCH-L3 activity, with an IC50of 25 μM[1]. LDN-57444 (LDN, 5 μM for 1 hr) inhibits 70% of Uch activity in hippocampal slices of the mouse brain. LDN-57444 (5 μM for 2 hr) does not reduce potentiation further in APP/PS1 slices or in wt slices exposed to 200 nM Aβ[2]. LDN-57444 (25-100 μM) inhibits ubiquitin-proteasome activity dose-dependently in SK-N-SH cells. LDN-57444 (50 μM) also induces apoptotic cell death, causes the endoplasmic reticulum stress and results in expression of spliced XBP-1(XBP-1s, 48KD) in SK-N-SH cells[3]. | ||||||||||||||||
体内研究 (In Vivo) | LDN-57444 (0.4 mg/kg, i.p.) blocks the beneficial effect of V-Uch-L1, and worsens contextual conditioning performance as the mice are exposed to the context at 1, 7, 14, and 21 days after training[2]. | ||||||||||||||||
分子量 | 397.64 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C17H11Cl3N2O3 | ||||||||||||||||
CAS 号 | 668467-91-2 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 25 mg/mL(62.87 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*以上所有助溶剂都可在本网站选购。 |